Skip to main content

Table 6 Parameters correlating with hydronephrosis

From: Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer

Parameter

Hydronephrosis absent

Hydronephrosis present

p-value

(§ Chi-square;

# Fisher’s exact)

T-stage BCa at initial diagnosis

  

< 0.0001 §

 pTa

45.7% (250/547)

20.0% (16/80)

 

 pT1

31.6% (173/547)

22.5% (18/80)

 

 pT2

22.7% (124/547)

57.5% (46/80)

 

 miscellaneous

1.1% (6/553)

4.8% (4/84)

 

Grading (WHO 1973) BCa at initial diagnosis

  

0.012 §

 G1

19.7% (109/553)

12.2% (10/82)

 

 G2

45.8% (253/553)

36.6% (30/82)

 

 G3

34.5% (191/553)

51.2% (42/82)

 

 unknown

0% (0/553)

2.4% (2/84)

 

Grading (WHO 2004) BCa at initial diagnosis

  

0.033 §

 low-grade

22.8% (120/526)

12.3% (10/81)

 

 high-grade

77.2% (406/526)

87.7% (71/81)

 

 unknown

4.9% (27/553)

3.6% (3/84)

 

Type of urinary drainage

  

< 0.0001 #

 DJ

100% (38/38)

50.0% (36/72)

 

 nephrostomy

0% (0/38)

50.0% (36/72)

 
  1. Data includes synchronous UUTUCs; n = 637 (n = 110 for urinary drainage of the upper urinary tract analysis); miscellaneous includes BCa staging >pT2, pTis and PUNLMP; “miscellaneous” and “unknown” categories were excluded from statistical analyses
  2. BCa bladder cancer, WHO World Health Organization